previous compound ID: 1320 next compound
InChIKey: LULNWZDBKTWDGK-UHFFFAOYSA-M
SMILES: CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C.[Br-]

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "J Liao" "JW Hanrahan" "DY Thomas" "SD Macknight" "J Goepp" "GW Carlile" "E Matthes" "R Robert" "D Rotin"

chemical graph of compound 1320





CID is 8246
synonyms found at PubChem are:
neostigmine bromide, 114-80-7, neo-Proserin, Eustigmin bromide, Neoserine bromide, Proserine bromide, Stigmanol bromide, Synstigmin bromide, Leostigmine bromide, Kirkstigmine bromide, Philostigmin bromide, Prostigmin, Stigmosan bromide, Prostigmin bromide, Neostigmine methyl bromide, Prostigmine bromide, Neostigmini bromidum, Synstigmini bromidum, Syntostigmin bromide, Vagostigmine bromide, Vagostigmin, 3-((Dimethylcarbamoyl)oxy)-N,N,N-trimethylbenzenaminium bromide, Syntostigmine bromide, Synthostigmine bromide, Syntostigmin (tablet), Bromure de neostigmine, Bromuro de neostigmina, Neostigmine (Bromide), Neostigmina bromuro [DCIT], UNII-005SYP50G5, Neostigmini bromidum [INN-Latin], EINECS 204-054-8, Bromure de neostigmine [INN-French], Bromuro de neostigmina [INN-Spanish], 3-Dimethylcarbamoxyphenyl trimethyl ammonium bromide, MLS000028387, (m-Hydroxyphenyl)trimethylammonium bromide dimethylcarbamate, 3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium bromide, 3-Hydroxyphenyltrimethylammonium bromide dimethylcarbamic ester, CHEBI:179557, 005SYP50G5, SMR000058591, Vagostigmin (TN), Carbamic acid, dimethyl-, ester with (m-hydroxyphenyl)trimethylammonium bromide, DSSTox_CID_21075, DSSTox_RID_79621, DSSTox_GSID_41075, W-108598, 3-(Dimethylcarbamoyloxy)trimethylanilinium ion Bromatum, Synstigminbromid, 3-(N,N-Dimethylcarbamoyloxy)-N,N,N,-trimethylanilinium bromide, 3-[[(Dimethylamino)carbonyl]oxy]-N,N,N-trimethylbenzenaminium bromide, 59-99-4 (Parent), AMMONIUM, (m-HYDROXYPHENYL)TRIMETHYL-, BROMIDE, DIMETHYLCARBAMATE, Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-, bromide, Benzenaminium, 3-[[(dimethylamino)carbonyl]oxy]-N,N,N-trimethyl-, bromide, Neostigmina bromuro, SR-01000000073, NCGC00163240-01, CAS-114-80-7, [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium;bromide, stigmanolbromide, stigmosanbromide, Neo proserine, C12H19N2O2.Br, synstigminbromide, syntostigminbromide, vagostigminebromide, syntostigminebromide, synthostigminebromide, Prestwick_352, syntostigmin(tablet), Neostigmine bromide [INN:BAN:JAN], Prostigmin;Vagostigmin, Neostigmine bromide [USP:INN:BAN:JAN], AC1L1QKY, Opera_ID_1504, NEOSTIGIMINE BROMIDE, AC1Q1RH0, SCHEMBL41128, MLS001146913, CHEMBL54126, SPECTRUM1500428, DTXSID9041075, Neostigmine bromide (Prostigmin), HMS500I07, KS-00000YWF, MolPort-003-666-242, HMS1569M18, HMS1920P15, HMS2091H18, HMS2096M18, HMS2235J11, HMS3262D13, HMS3372E02, HMS3713M18, Pharmakon1600-01500428, Eustigmin bromide;Neoserine bromide, ACT05638, HY-B0423, Neostigmine bromide (JAN/USP/INN), Tox21_112037, Tox21_500816, AN-333, BG0265, CCG-39110, GK7491, MFCD00011795, NSC757233, s2490, AKOS015895725, Tox21_112037_1, API0003538, CS-2529, LP00816, MCULE-9726153183, NSC-757233, NCGC00015730-11, NCGC00094149-01, NCGC00094149-02, NCGC00094149-03, NCGC00094149-04, NCGC00261501-01, AK162162, LS-18446, Q562, SC-19050, MLS-0002855.P042, AB0004770, AB2000595, AX8144170, EU-0100816, FT-0083763, FT-0651572, N0358, ST24041334, ST50411544, C08197, D00995, N 2001, A803245, SR-01000000073-3, SR-01000000073-5, SR-01000000073-7, (3-Dimethylcarbamoyloxyphenyl)trimethylammonium Bromide, [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium bromide, (m-Hydroxyphenyl)trimethyl-ammonium bromide dimethylcarbamate, [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-ammonium bromide, N,N-dimethyl[3-(trimethylamino)phenoxy]carboxamide, bromide, Neostigmine bromide, >=98% (HPLC and titration), powder, (3-Hydroxyphenyl)trimethylammonium Bromide Dimethyl Carbamate, [3-[dimethylamino(oxo)methoxy]phenyl]-trimethylammonium bromide, Neostigmine bromide, European Pharmacopoeia (EP) Reference Standard, Neostigmine bromide, United States Pharmacopeia (USP) Reference Standard